MAP2K4 Antikörper (AA 259-398)

Produktnummer ABIN7150711

Produktdetails anti-MAP2K4 Antikörper

Target: MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

Bindungsspezifität: AA 259-398

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MAP2K4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Dual specificity mitogen-activated protein kinase kinase 4 protein (259-398AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:5000, IHC:1:100-1:500, IF:1:50-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu MAP2K4

Target: MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

Andere Bezeichnung: MAP2K4 (MAP2K4 Produkte)

Synonyme: JNKK antikoerper, JNKK1 antikoerper, MAPKK4 antikoerper, MEK4 antikoerper, MKK4 antikoerper, PRKMK4 antikoerper, SAPKK-1 antikoerper, SAPKK1 antikoerper, SEK1 antikoerper, SERK1 antikoerper, SKK1 antikoerper, Sek1 antikoerper, Serk1 antikoerper, MKK4A-l antikoerper, map2k4 antikoerper, zgc:136500 antikoerper, jnkk antikoerper, mek4 antikoerper, mkk4 antikoerper, sek1 antikoerper, jnkk1 antikoerper, serk1 antikoerper, xmek2 antikoerper, mapkk4 antikoerper, prkmk4 antikoerper, 142758_at antikoerper, CG9738 antikoerper, CT27508 antikoerper, D-MKK4 antikoerper, DMKK4 antikoerper, Dmel\\CG9738 antikoerper, JNKK2 antikoerper, Mpk4 antikoerper, SEK1/MKK4 antikoerper, dMKK4 antikoerper, dMkk4 antikoerper, hep antikoerper, ARABIDOPSIS THALIANA MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 antikoerper, ATMEK4 antikoerper, ATMKK4 antikoerper, F19C24.26 antikoerper, F19C24_26 antikoerper, MAP KINASE KINASE 4 antikoerper, mitogen-activated protein kinase kinase 4 antikoerper, MKK4B antikoerper, zgc:194486 antikoerper, mitogen-activated protein kinase kinase 4 antikoerper, mitogen-activated protein kinase kinase 4a antikoerper, MAP kinase kinase 4 antikoerper, mitogen activated protein kinase kinase 4 antikoerper, mitogen-activated protein kinase kinase 4b antikoerper, MAP2K4 antikoerper, Map2k4 antikoerper, map2k4a antikoerper, map2k4 antikoerper, Mkk4 antikoerper, MKK4 antikoerper, map2k4b antikoerper

Hintergrund:

Background: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Aliases: c Jun N terminal kinase kinase 1 antibody, C-JUN N-terminal kinase kinase 1 antibody, Dual specificity mitogen activated protein kinase kinase 4 antibody, Dual specificity mitogen-activated protein kinase kinase 4 antibody, JNK Activated Kinase 1 antibody, JNK activating kinase 1 antibody, JNK-activating kinase 1 antibody, JNKK antibody, JNKK1 antibody, MAP kinase kinase 4 antibody, Map2k4 antibody, MAPK ERK kinase 4 antibody, MAPK/ERK kinase 4 antibody, MAPKK 4 antibody, MAPKK4 antibody, MEK 4 antibody, MEK4 antibody, Mitogen activated protein kinase kinase 4 antibody, MKK 4 antibody, MKK4 antibody, MP2K4_HUMAN antibody, PRKMK4 antibody, SAPK ERK kinase 1 antibody, SAPK/ERK kinase 1 antibody, SAPKK 1 antibody, SAPKK1 antibody, SEK1 antibody, SERK1 antibody, SKK1 antibody, Stress activated protein kinase kinase 1 antibody

UniProt: P45985

Pathways: MAPK Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, BCR Signaling